New vaccine billionaires gain wealth as Moderna, Pfizer shares soar
Pfizer CEO Read to Step Aside at Year's End - WSJ
Albert Bourla: Net Worth, Biography, Age, Career, Salary & More - MTM
Pfizer CEO Albert Bourla on developing a COVID vaccine in less than a year | Fortune
Pfizer CEO: What's next for vaccines, tech and the pandemic | World Economic Forum
Three Billionaires Behind Pfizer's Vaccine Partner BioNTech Are $2 Billion Richer After It Announces Covid-19 Vaccine Results
Chart: Pfizer Revenue Boosted by Covid-19 Drugs | Statista
Albert Bourla won't testify in front of the European Parliament
Albert Bourla - Chief Executive Officer - Pfizer | LinkedIn
Covid vaccine profits mint 9 new pharma billionaires | CNN Business
Albert Bourla: Net Worth, Biography, Age, Career, Salary & More - MTM
Pfizer chief sold $5.6m of shares as investors hailed vaccine | Financial Times
Pfizer Net Worth 2023: Assets Net Income Revenue PE Ratio
Vaccine Capitalism: a run-down of the huge profits being made from COVID-19 vaccines - Corporate Watch
Washington DC's 500 Most Influential People
Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021
From Pfizer to Moderna: who's making billions from Covid-19 vaccines? | Pharmaceuticals industry | The Guardian
Dr. Albert Bourla | Pfizer
Pfizer expects $15B in COVID-19 vaccine sales in 2021; some analysts see more | S&P Global Market Intelligence
Pfizer expects $15B in COVID-19 vaccine sales in 2021; some analysts see more | S&P Global Market Intelligence
Pfizer CEO Albert Bourla sold stock the day he announced promising vaccine news | CNN Business
The CEO of Pfizer on Developing a Vaccine in Record Time
Lucky Pfizer CEO Bourla cashes out $5.6M worth of stock—perfectly legally—as COVID-19 vaccine data lift market | Fierce Pharma
The CEO of Pfizer on Developing a Vaccine in Record Time
Pfizer CEO gets 61% pay raise—to $27.9 million—as drug prices continue to climb | Ars Technica
